Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.006955
+0.000155 (2.28%)
At close: Apr 17, 2026
Petros Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
294.70K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 5.11M | -710.35K | -12.20% |
| Dec 31, 2023 | 5.82M | -169.67K | -2.83% |
| Dec 31, 2022 | 5.99M | -1.82M | -23.29% |
| Dec 31, 2021 | 7.81M | -1.75M | -18.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| StateHouse Holdings | 103.72M |
| Ecofibre | 17.56M |
| Fifty 1 Labs | 4.08M |
| BioTech Medics | 469.80K |
| TransGlobal Assets | 91.35K |
| Branded Legacy | 87.65K |
| Neutra | 66.07K |
| Green Rain Energy Holdings | 2.63K |
Petros Pharmaceuticals News
- 10 months ago - Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position - Accesswire
- 11 months ago - Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets - Accesswire
- 11 months ago - Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer - Accesswire
- 1 year ago - Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform - Accesswire
- 1 year ago - Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches - Accesswire
- 1 year ago - Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms - Accesswire
- 1 year ago - Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications - Accesswire
- 1 year ago - Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study - Accesswire